Sitemap
- The Penn Scleroderma Center: A Leader in Scleroderma
-
Research
-
Active Research Studies
- A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis
- CONQUER
- GRASP
- Evaluating X-Chromosome Inactivation Maintenance in a Cross-sectional Cohort of Patients with Systemic Sclerosis
- SCTC White Paper Initiative
- Recently Completed Research Studies
- Being a Research Participant
- Selection of Publications by the Penn Scleroderma Center
-
Active Research Studies
- Patient Care